← All trials
NCT05608590
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 22, 2019
- Primary completion
- Apr 1, 2023
- Completion date
- Jan 1, 2025
- First posted
- Nov 8, 2022
- Last posted
- Nov 8, 2022
- Enrollment
- 554
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Free University of AmsterdamLead sponsor
- ZonMw: The Netherlands Organisation for Health Research and DevelopmentCollaborator
- Free University of AmsterdamReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.